Fragile-X Syndrome Clinical Research Study
        
     
    
        
    
    
        Project Description:
        A RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, SAFETY AND EXPLORATORY EFFICACY AND PHARMACOKINETIC, STUDY OF RO4917523 IN PEDIATRIC PATIENTS WITH FRAGILE X SYNDROME
     
    
        Keyword(s):
        collaborative study,  Fragile-X
     
    
        Core Function(s):
        Performing Research or Evaluation
     
    
        Area of Emphasis
        Health-Related Activities
     
    
        Target Audience:
        Children/Adolescents with Disabilities/SHCN
     
    
        Unserved or Under-served Populations:
        Specific Groups
     
    
        Primary Target Audience Geographic Descriptor:
        National
     
    
    
        COVID-19 Related Data:
        
                N/A